The Glucagon Receptor Is Involved in Mediating the Body Weight‐Lowering Effects of Oxyntomodulin
Open Access
- 1 August 2012
- Vol. 20 (8), 1566-1571
- https://doi.org/10.1038/oby.2012.67
Abstract
Oxyntomodulin (OXM) is a peptide secreted postprandially from the L‐cells of the gut that has a weak affinity for both the glucagon‐like peptide‐1 receptor (GLP1R) and the glucagon receptor (GCGR). Peripheral administration of OXM in humans and rodents causes weight loss reducing food intake and increasing energy expenditure. It has been suggested that OXM modulates energy intake solely through GLP1R agonism. Because glucagon decreases food intake in rodents and humans, we examined whether activation of the GCGR is involved in the body weight‐lowering effects of OXM. We identified an equipotent GLP1R‐selective peptide agonist that differs from OXM by only one residue (Q3→E, OXMQ3E), but has no significant GCGR agonist activity in vitro and ∼100‐fold reduced ability to stimulate liver glycogenolysis. Chronic treatment of obese mice with OXM and OXMQ3E demonstrated that OXM exhibits superior weight loss and lipid‐lowering efficacy, and antihyperglycemic activity that is comparable to the corresponding GLP1R‐selective agonist. Studies in Glp1r−/− mice and coadministration of OXM and a GCGR antagonist revealed that the antiobesity effect of OXM requires activation of both GLP1R and GCGR. Our data provide new insight into the mechanism of action of OXM and suggest that activation of GCGR is involved in the body weight‐lowering action of OXM.Keywords
This publication has 31 references indexed in Scilit:
- Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axisJCI Insight, 2011
- Pharmacological Targeting of Glucagon and Glucagon-Like Peptide 1 Receptors Has Different Effects on Energy State and Glucose Homeostasis in Diet-Induced Obese MiceJournal of Pharmacology and Experimental Therapeutics, 2011
- The metabolic actions of glucagon revisitedNature Reviews Endocrinology, 2010
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in MiceDiabetes, 2009
- Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI)NeuroImage, 2009
- Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptorAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imagingBiochemical and Biophysical Research Communications, 2006
- Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trialInternational Journal of Obesity, 2006
- A role for glucagon-like peptide-1 in the central regulation of feedingNature, 1996
- Stimulation of Feeding in Rats by Intraperitoneal Injection of Antibodies to GlucagonScience, 1982